Results 91 to 100 of about 68,927 (203)

Intravenous 1,25(OH)2 Vitamin D3 Therapy in Haemodialysis Patients: Evaluation of Direct and Calcium-Mediated Short-Term Effects on Serum Parathyroid Hormone Concentration [PDF]

, 2017
Eleven patients on chronic haemodialysis treatment thrice weekly received 1 μg 1,25(OH)2D3 i.v. after each dialysis for 3 weeks. Phosphate binders were mainly CaCO3, supplemented in a few patients by moderate amounts of A1(OH)3.
Binswanger, U., Fischer, J. A., Probst, W.   +2 more
core  

The azygos vein as an alternative route for haemodialysis catheterisation

European Journal of Case Reports in Internal Medicine
Introduction: Central venous catheterisation (CVC) is essential for haemodialysis in end-stage kidney disease, but superior vena cava (SVC) stenosis or occlusion often complicates long-term access. The azygos vein, a collateral drainage pathway, has been
Vladimir Pushevski, Filip Janusevski, Zoran Janevski, Petar Dejanov   +3 more
doaj   +1 more source

Intermittent Haemodialysis [PDF]

BMJ, 1965
openaire   +2 more sources

Prevalence of Anti-HCV antibody in haemodialysis patients referring to haemodialysis centers in Jahrom

فصلنامه دانشگاه علوم پزشکی جهرم, 2007
Introduction: Hepatitis C virus (HCV) is a major cause of chronic liver disease among chronic renal failure (CRF) patients undergoing maintenance hemodialysis.The Management of HCV-related liver disease is a major health concern in patients with end ...
Reza Stoodeh Jahromi, forogh Nejatollahi, mohammad mehdi Hossaini   +2 more
doaj  

Hearing loss in patients with chronic kidney disease undergoing haemodialysis [PDF]

Al Ameen Journal of Medical Sciences
Background: Haemodialysis is a treatment for chronic renal failure/chronic kidney disease that significantly reduce the morbidity and postpone the mortality. However, studies have reported that in these patients, hearing loss symptoms were increasing and
Thimmappa T.D, Gangadhar K.S, Ramesh S, Manjula B   +3 more
doaj  

Takotsubo Syndrome in the Dialysis Patient - Challenging Diagnosis in a Unique Population. [PDF]

, 2019
Banerjee, Charlotte Perrett, Debasish Banerjee, Foley, Ghadri, Lyon, Pelliccia, Y-Hassan, Yassin, Zbroch   +9 more
core   +1 more source

WCN25-3186 Quality of life of patients with stage 3 to 5 chronic kidney disease followed in the nephrology and haemodialysis department of the CHU Yalgado Ouédraogo: Cross-sectional survey

Kidney International Reports
Juste Yeremade Bonzi, Zoéhinga Patrice, Fulbert OUEDRAOGO, Gérard Coulibaly, Gaoussou Sanou   +4 more
doaj   +1 more source

Feet in Peril: Assessment of Feet in Patients Undergoing Haemodialysis. [PDF]

J Ren Care
Ünal A, Eşsiz SD, Yılmaz Ü, Bal Özkaptan B, Ozen N.   +4 more
europepmc   +1 more source

WCN25-3190 Addressing the Failure of Arteriovenous Fistulas at the Nephrology and Hemodialysis Department of a Subsaharan Tertiary Hospital: A Critical Clinical Audit

Kidney International Reports
Juste Yeremade Bonzi, Daniel DAH, COULIBALY Gérard   +2 more
doaj   +1 more source

Association between plasma concentrations of galectin 3, growth differentiation factor 15, soluble suppression of tumourigenicity 2, and cystatin C and clinical parameters and survival in patients with end-stage renal disease undergoing haemodialysis. [PDF]

Amino Acids
Ptak M, Cader-Ptak A, Marcinowska Z, Dziedziejko V, Safranow K, Kwiatkowska E, Ciechanowski K, Pawlik A, Domański L.   +8 more
europepmc   +1 more source